EMPA-REG: Glucose excretion and lipid mobilization - not storage - saves lives

J Diabetes Complications. May-Jun 2016;30(4):753. doi: 10.1016/j.jdiacomp.2016.02.015. Epub 2016 Feb 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Benzhydryl Compounds / therapeutic use*
  • Cardiotonic Agents / therapeutic use*
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / mortality
  • Diabetic Angiopathies / prevention & control
  • Diabetic Cardiomyopathies / metabolism
  • Diabetic Cardiomyopathies / mortality
  • Diabetic Cardiomyopathies / prevention & control*
  • Glucose / metabolism
  • Glucosides / therapeutic use*
  • Heart / drug effects*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Lipid Metabolism / drug effects
  • Myocardium / metabolism*
  • Randomized Controlled Trials as Topic
  • Sodium-Glucose Transporter 2 / metabolism
  • Sodium-Glucose Transporter 2 Inhibitors

Substances

  • Benzhydryl Compounds
  • Cardiotonic Agents
  • Glucosides
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • empagliflozin
  • Glucose